Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to gather scientific information about the
effectiveness and safety of the study drug, Ecopipam (PSYRX 101), for the treatment of
self-injurious behaviors when compared with the effectiveness and safety of placebo (inactive
substance) in subjects with Lesch-Nyhan Disease.